CADENCE PHARMACEUTICALS INC
DelistedCIK 1333248fmd_03XVBM18YMRXZABDYDQTRKAHV3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2013, 16 periods
Latest annual · FY2013
Millions- Total revenues
- 113
- Gross profit
- 75
- Operating income
- (28)
- Net income
- (24)
- Free cash flow
- (24)
Latest quarter · Q4 FY2013
Millions- Total revenues
- 35
- Gross profit
- 24
- Operating income
- (3)
- Net income
- (4)
- Free cash flow
- 0
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2010 to FY2013
- n/m
CADENCE PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2013 | FY2012 | Change | Source |
|---|---|---|---|---|
| Revenue | $112.6 million | $50.2 million | +124.3% | 10-K 2014-02-28 · proof |
| Gross profit | $74.6 million | $26.9 million | +177% | 10-K 2014-02-28 · proof |
| Operating income | -$27.5 million | -$76.7 million | 10-K 2014-02-28 · proof | |
| Net income | -$24.3 million | -$81 million | 10-K 2014-02-28 · proof | |
| Cash from operating activities | -$23.2 million | -$64.3 million | 10-K 2014-02-28 · proof | |
| Free cash flow | -$23.7 million | -$66 million | 10-K 2014-02-28 · proof | |
| Total assets | $90.8 million | $97.7 million | -7% | 10-K 2014-02-28 · proof |
| Total liabilities | $55.9 million | $49.9 million | +12.1% | 10-K 2014-02-28 · proof |
| Cash and cash equivalents | $55.1 million | $58.3 million | -5.6% | 10-K 2014-02-28 · proof |
| Total debt | $29.3 million | 10-K 2014-02-28 · proof |
- What was CADENCE PHARMACEUTICALS INC's revenue in fiscal 2013?
- CADENCE PHARMACEUTICALS INC reported revenue of $112.6 million for fiscal 2013 (the year ended Dec 31, 2013), against $50.2 million the year before (+124.3%). Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What was CADENCE PHARMACEUTICALS INC's gross profit in fiscal 2013?
- CADENCE PHARMACEUTICALS INC reported gross profit of $74.6 million for fiscal 2013 (the year ended Dec 31, 2013), against $26.9 million the year before (+177%). Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What was CADENCE PHARMACEUTICALS INC's operating income in fiscal 2013?
- CADENCE PHARMACEUTICALS INC reported operating income of -$27.5 million for fiscal 2013 (the year ended Dec 31, 2013), against -$76.7 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What was CADENCE PHARMACEUTICALS INC's net income in fiscal 2013?
- CADENCE PHARMACEUTICALS INC reported net income of -$24.3 million for fiscal 2013 (the year ended Dec 31, 2013), against -$81 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What was CADENCE PHARMACEUTICALS INC's cash from operating activities in fiscal 2013?
- CADENCE PHARMACEUTICALS INC reported cash from operating activities of -$23.2 million for fiscal 2013 (the year ended Dec 31, 2013), against -$64.3 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What was CADENCE PHARMACEUTICALS INC's free cash flow in fiscal 2013?
- CADENCE PHARMACEUTICALS INC reported free cash flow of -$23.7 million for fiscal 2013 (the year ended Dec 31, 2013), against -$66 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What are CADENCE PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2013, CADENCE PHARMACEUTICALS INC reported total assets of $90.8 million, against $97.7 million a year earlier (-7%). Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What are CADENCE PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2013, CADENCE PHARMACEUTICALS INC reported total liabilities of $55.9 million, against $49.9 million a year earlier (+12.1%). Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What are CADENCE PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2013, CADENCE PHARMACEUTICALS INC reported cash and cash equivalents of $55.1 million, against $58.3 million a year earlier (-5.6%). Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
- What is CADENCE PHARMACEUTICALS INC's total debt?
- As of Dec 31, 2013, CADENCE PHARMACEUTICALS INC reported total debt of $29.3 million. Source: the 10-K filed with the SEC on Feb 28, 2014. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1333248&period_type=annual&limit=5"Information only, not investment advice.